UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

X . QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, ~~2010~~2011

. TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from ______ to _______

Commission File Number 000-30237

REGENECA, INC.

(Exact name of issuer as specified in its charter)


Nevada		88-0467241
(State of incorporation)		(I.R.S. Employer Identification No.)

1 Technology, Suite C515

Irvine, CA 92618

(Address of principal executive offices)

(800) 690-6958

(Registrant's telephone number, including area code)

Ethos Environmental, Inc.

(Former Name)

with a copy to:

Christopher A. Wilson, Esq.

Wilson, Haglund & Paulsen, P.C.

9110 Irvine Center Drive

Irvine, CA 92618

Telephone: (949) 752-1100 ext. 302

Facsimile (949) 752-1144

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes . No X .

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). .

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.


Large accelerated filer	.	Accelerated filer	.
Non-accelerated filer	. (Do not check if a smaller reporting company)	Smaller reporting company	X .

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes . No X .

As of September 30, ~~2010~~2011, (the last day of the fiscal quarter to which this report relates), there were ~~102~~928,~~226~~590,~~177~~209 common shares of the registrant’s $.0001 par value common stock issued and outstanding, and as of ~~September~~December 220, 2011 (the latest practical date) there were ~~952~~875,~~844~~999,~~037~~590 common shares outstanding.

REGENECA, INC. *

TABLE OF CONTENTS

		Page
PART I. FINANCIAL INFORMATION		3
ITEM 1.	CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	3
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	1314
ITEM 3.	QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK	1516
ITEM 4.	CONTROLS AND PROCEDURES	1516
PART II. OTHER INFORMATION		1617
ITEM 1.	LEGAL PROCEEDINGS	1617
ITEM 1A.	RISK FACTORS	1617
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	1617
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	1618
ITEM 4.	[REMOVED AND RESERVED]	1618
ITEM 5.	OTHER INFORMATION	1618
ITEM 6.	EXHIBITS	1718

Special Note Regarding Forward-Looking Statements

Information included in this Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”). This information may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Regeneca, Inc., formerly know as Ethos Environmental, Inc. (the “Company”), to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements. Forward-looking statements, which involve assumptions and describe future plans, strategies and expectations of the Company, are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. These forward-looking statements are based on assumptions that may be incorrect, and there can be no assurance that these projections included in these forward-looking statements will come to pass. Actual results of the Company could differ materially from those expressed or implied by the forward-looking statements as a result of various factors. Except as required by applicable laws, the Company has no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.

*Please note that throughout this Quarterly Report, and except as otherwise indicated by the context, references in this report to “Company,” “ETEV,” “RGNA” “Ethos Environmental, Inc.”, “Ethos” “we,” “us” and “our” are references to Regeneca, Inc.

PART I - FINANCIAL INFORMATION

ITEM 1.

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Index

Condensed Consolidated Balance Sheets

Condensed Consolidated Statements of Operations

Condensed Consolidated Statements of Cash Flows

Notes to the Condensed Consolidated Financial Statements

REGENECA, INC.

(Formerly Known As Ethos Environmental, Inc.)

Condensed Consolidated Balance Sheets

		September 30, 2010 (unaudited)		December 31, 2009
		September 30, 2011 (unaudited)		December 31, 2010
ASSETS
Current Assets
Current assets
Cash	$	60453,~~226~~504	$	~~347~~216,~~954~~476
Accounts Receivable, net of allowance of doubtful accounts		20,379		14,593
Accounts receivable		46,748		1,982
Inventory		8269,~~689~~664		89129,~~678~~541
Total Current Assets		89,294		452,225
Prepaid license fee		222,638		102,638
Property and Equipment		5,819		22,992
Other current assets		279,249		8,027
Other Assets		13,726		417,917
Total current assets		1,271,803		458,664
Total Assets	$	108,839	$	893,134
Prepaid license fee – long-term		482,493		96,568
Furniture and equipment, net		7,525		6,302
Other assets		75,000		–
Total assets	$	1,836,821	$	561,534
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Current liabilities
Accounts Payable	$	1,534,756	$	1,467,605
Accounts payable	$	731,902	$	208,902
Notes Payable		1,950,000		1,750,000
Accrued liabilities		620,599		26,498
Convertible Debenture		1,050,631		859,102
Convertible notes payable, net of discounts		1,134,787		204,717
Total Liabilities		4,535,387		4,076,707
Derivative liabilities		332,203		108,576
Stockholders’ Deficit
Advances payable to related parties		212,362		180,555
Common Stock Authorized: 1,000,000,000 shares, par value: $0.0001 per share issued and outstanding: 102,226,177 and 102,150,306 shares, respectively		10,223		10,215
Total current liabilities		3,031,853		729,248
Additional Paid-In Capital		62,027,082		62,018,089
Commitments and contingencies (note 8)
Accumulated Deficit		(66,463,853)		(65,211,877)
Stockholders’ deficit:
Total Stockholders’ Deficit		(4,426,548)		(3,183,573)
Common stock, $0.0001 par value; 1,900,000,000 and 1,000,000,000 common shares authorized, 928,590,209 and 824,444,037 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively		92,859		82,444
Total Liabilities and Stockholders’ Deficit	$	108,839	$	893,134
Additional paid-in capital		5,484,196		3,172,151
Accumulated deficit		(6,772,087)		(3,422,309)
Total stockholders’ deficit		(1,195,032)		(167,714)
Total liabilities and stockholders’ equity	$	1,836,821	$	561,534

The accompanying notes are an integral part of these condensed consolidated financial statements.

REGENECA, INC.

(Formerly Known As Ethos Environmental, Inc.)

Condensed Consolidated Statements of Operations

(~~Unaudited~~unaudited)

		For the three months ended				For the nine months ended
		September 30, 2010		September 30, 2009		September 30, 2010		September 30, 2009
		September 30, 2011		September 30, 2010		September 30, 2011		September 30, 2010
Revenue	$	90403,~~277~~700	$	~~417~~13,~~381~~474	$	~~378~~2,~~284~~475,536	$	182,~~026,685~~456
Cost of Sales		44,391		164,878		187,484		406,857
Cost of sales		69,183		1,469		572,335		9,471
Gross Profit		45,886		252,503		190,800		619,828
Gross profit		334,517		12,005		1,903,201		72,985
Operating Expenses
Operating expenses
Depreciation and Amortization Expense		92,988		62,765		208,702		139,736
Depreciation and amortization expenses		43,485		26,451		96,081		79,186
Bad Debt Expense		–		–		–		14,979
Selling, general and administrative expenses		1,136,607		474,992		5,453,096		895,190
General and Administrative		154,079		795,759		822,421		3,907,558
Total operating expenses		1,180,092		501,443		5,549,177		974,376
Selling Expense		45,589		42,441		168,093		266,464
Loss from operations		(845,575)		(489,438)		(3,645,976)		(901,391)
Total Operating Expenses		292,656		900,965		1,199,216		4,328,737
Other (income) expenses
Total Operating Loss		(246,770)		(648,462)		(1,008,416)		(3,708,909)
Change in fair value of derivative liabilities		(702,503)		–		(1,395,013)		–
Other Income (Expenses)
Loss on disposal of assets		–		–		5,511		–
Interest Expense		(85,868)		(114,313)		(257,616)		(284,349)
Interest		745,328		1,510		1,093,304		2,317
Gain on Settlement of Debt		–		(75,674)		14,411		(139,674)
		42,825		1,510		(296,198)		2,317
Other Income (Expense)		–		–		(355)		4,118
Net loss before income taxes		(888,400)		(490,948)		(3,349,778)		(903,708)
Net Loss	$	(332,638)	$	(838,449)	$	(1,251,976)	$	(4,128,814)
Income taxes		–		–		–		–
Net Loss Per Share – Basic and Diluted	$	(0.00)	$	(0.02)	$	(0.01)	$	(0.09)
Net loss	$	(888,400)	$	(490,948)	$	(3,349,778)	$	(903,708)
Weighted Average Shares Outstanding		102,226,177		48,476,702		102,226,177		47,160,629
Basic and diluted loss per common share
Basic and diluted	$	(0.00)	$	(0.00)	$	(0.00)	$	(0.00)
Weighted average common shares outstanding - basic and diluted		881,658,244		312,594,322		855,473,739		223,209,712

The accompanying notes are an integral part of these condensed consolidated financial statements.

REGENECA, INC.

~~(Formerly~~Condensed ~~Known~~Consolidated AsStatements ~~Ethos~~of ~~Environmental,~~Cash ~~Inc.)~~Flows

~~Condensed Consolidated Statements of Cash Flow~~ (unaudited)

(Unaudited)


		For the nine months ended
		September 30, 2011		September 30, 2010

Cash flows from operating activities
Net loss	$	(3,349,778)	$	(903,708)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		246,081		79,186
Change in estimated fair value of derivative liabilities		(1,395,013)		–
Amortization of debt discount		946,546		–
Loss on disposal of asset		5,511		–
Fair value of stock issued for services		100,000		683,288
Fair value of stock issued for conversion of interest payable		30,878		–
Stock based compensation		106,245		–
Changes in operating assets and liabilities:
Accounts receivable		(44,766)		(703)
Inventories		(140,123)		(130,517)
Other current assets		(46,222)		29,498
Accounts payable		523,000		71,930
Accrued liabilities		594,101		4,186
Advances payable to related parties		31,807		93,684
Net cash used in operating activities		(2,391,733)		(73,156)

Cash flows from investing activities
Purchases of furniture and equipment		(8,739)		(2,500)
Net cash used in investing activities		(8,739)		(2,500)

Cash flows from financing activities
Proceeds from issuance of convertible debentures		2,537,500		125,000
Net proceeds from sale of common stock for cash		100,000		3,550
Net cash provided by financing activities		2,637,500		128,550

Net increase in cash		237,028		52,894

Cash – beginning of period		216,476		2,672

Cash – end of period	$	453,504	$	55,566

Supplemental disclosure of cash flow information
Interest paid during the period	$	23,452	$	807

Supplemental schedule of noncash investing and financing activities
Issuance of common stock in connection with the conversion of convertible notes payable	$	815,000	$	–
Issuance of common stock in connection with prepaid license fee	$	600,000	$	–
Issuance of common stock in connection with consulting agreement	$	450,000	$	-

		For the nine months ended
		September 30, 2010		September 30, 2009
Cash Flows From Operating Activities
Net Loss For The Period	$	(1,251,976)	$	(4,128,814)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and Amortization Expense		208,702		166,737
Bad Debt Expense		–		14,979
Common Stock Issued for Services		9,001		451,107
Common Stock Issued as Incentive Shares		–		270,880
Common Stock Issued for Settlement of Debt		–		209,948
Common Stock Issued for Payment of Interest		–		14,873
Loss on Settlement of Debt		–		139,674
Stock-based Compensation		–		483,266
Changes in operating assets and liabilities:
Accounts Receivable		(5,786)		65,422
Inventory		80,989		81,904
Other Assets		404,191		(12,499)
Accounts Payable and Accrued Liabilities		67,151		788,489
Net Cash Used In Operating Activities		(487,728)		(1,454,034)
Cash Flows From Financing Activities
Proceeds from Issuance of Notes Payable		200,000		1,349,686
Proceeds from Issuance of Common Shares		–		120,000
Net Cash Provided By Financing Activities		200,000		1,469,686
Increase (Decrease) in Cash		(287,728)		15,652
Cash – Beginning of Period		347,954		72,232
Cash – End of Period	$	60,226	$	87,884

The accompanying notes are an integral part of these condensed consolidated financial statements.

REGENECA, INC.

~~(Formerly~~Notes ~~Known~~to AsConsolidated ~~Ethos~~Financial ~~Environmental, Inc.)~~Statements

~~NOTES CONDENSED TO FINANCIAL STATEMENTS~~(unaudited)

September 30, 2011

~~Nature~~Organization ~~of Operations~~ and ~~Continuance of~~ Business

Regeneca International, Inc. ~~(the~~was ~~“Company”~~formed oron ~~“Regeneca”)~~January 9, ~~formerly~~2009 ~~Ethos~~in ~~Environmental,~~Nevada ~~Inc.,~~to ~~was~~create ~~incorporated~~and ~~under~~commercialize ~~the~~a ~~laws~~family of ~~the~~natural ~~State~~and oforganic ~~Nevada~~compound oninfused ~~January~~products ~~19,~~designed ~~1926.~~to ~~Until~~help ~~January~~improve 1,health. ~~2011,~~The ~~the~~ Company ~~was~~currently conducts operations primarily in the United States using a Direct Response Network Marketing business ofmodel. ~~manufacturing~~The ~~and~~Company’s ~~distribution~~primary ofproducts aare ~~unique~~RegenErect, ~~line~~an ofall-natural ~~engine~~male ~~cleaning~~enhancement product, and ~~lubrication~~RegeneSlim, a natural appetite suppressant. Sales are made to the consumer through the Company’s website and by independent representatives.

On December 31, 2010, Regeneca International, Inc. merged into a wholly-owned subsidiary of the Company (the “Merger”), and in which the Company issued to the former ~~shareholders~~stockholders of Regeneca ~~approximately~~International, Inc. 420,466,~~422~~494 shares of its common stock such that, immediately after the Merger, Regeneca International, Inc.’s former ~~shareholders~~stockholders owned approximately 51% of the combined post-Merger entity. The Company subsequently changed its name to “Regeneca, Inc.” The Merger was accounted for as a capital reorganization or a public shell “reverse merger.,” and, as such, the consolidated financial statements reported herein reflect the operations of Regeneca, Inc. within the new capital structure of the Company.

The Company ceased operations of its engine cleaning and lubrication business in January 2011.

Going Concern

~~These~~The ~~condensed consolidated~~ financial statements have been prepared onassuming that the Company will continue as a going concern. This basis, ~~which~~of ~~implies~~accounting ~~that~~contemplates the ~~Company~~recovery ~~will~~of ~~continue~~the toCompany’s ~~realize its~~ assets and ~~discharge~~the satisfaction of its liabilities in the normal course of business. AsSince ~~noted above~~inception, ~~Ethos Environmental, Inc. merged with~~ the Company onhas ~~December~~been ~~31,~~engaged ~~2010 and ceased its operations~~ in ~~January~~obtaining ~~2011.~~financing, ~~These~~recruiting ~~condensed~~personnel, ~~consolidated~~establishing ~~financial~~office ~~statements~~facilities ~~do not include any adjustments to the recoverability~~ and ~~classification~~developing ofits ~~recorded~~sales ~~asset amounts~~ and ~~classification~~marketing ~~of liabilities that might be necessary should the Company be unable to continue as a going concern~~strategy.

The Company does not have sufficient cash on hand to fund its administrative and other operating expenses or its proposed sales and marketing programs for the next twelve months. In 2011 through the date of this report, the Company issued $2,992,500 in convertible notes payable and issued common stock for $150,000 in cash to fund operations. The Company’s ability to become a profitable operating company is dependent upon obtaining financing adequate to fulfill its market introduction activities, and achieving a level of revenues adequate to support the Company’s cost structure. Management intends to finance the Company’s operations from loans and advances from current stockholders, future public and private debt and equity offerings and proceeds from product sales. However, there can be no assurance that additional capital will be available, which may affect the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Risks and Uncertainties

The Company’s research and development activities and the manufacturing and marketing of the Company’s products may be subject to the laws, regulations and guidelines, and, in some cases, regulatory approvals, of governmental authorities in the United States and other countries in which the Company’s products are or will be marketed. Specifically, in the United States, the Food and Drug Administration (the “FDA”) regulates, among other areas, new drug and cosmetic product approvals, over the counter drugs and clinical trials of new products and services to establish the proper labeling, safety and efficacy of these products and services and the accuracy of certain marketing claims.

On May 27, 2011, the Company received a warning letter from the FDA dated May 25, 2011 (the “Warning Letter”). The Warning Letter asserts that the FDA tested lots of the Company’s dietary supplement, “RegenErect”, and concluded that it contained a pharmaceutical ingredient and is, therefore, subject to regulation as a new prescription drug, requiring FDA approval before introduction and delivery. FDA lab analysis has confirmed the presence of Sulfoaildenafil, an analogue of Sildenafil, making these products unapproved new drugs. Sildenafil is an FDA-approved drug used as treatment for male Erectile Dysfunction (“ED”). The active drug ingredient is not listed on the label for these products.

According to the FDA, use of these products may pose a threat to consumers because the analogue may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels. FDA has advised that consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. FDA has advised that ED is a common problem in men with these conditions, and consumers may seek these types of products to enhance sexual performance.

The FDA also asserts that, because it is a new prescription drug, RegenErect is misbranded as a dietary supplement, and that the advertising and promotional claims of the Company exceed the claims permitted for dietary supplements. The Warning Letter required the Company to respond within 15 days, disclosing the specific steps taken to correct the alleged violations. The Company responded to the Warning Letter and also undertook a voluntary national recall of certain lots of the Company’s “RegenErect” product.

If unresolved, the claims in the Warning Letter would have a substantial impact on the Company’s ability to market and sell RegenErect and would materially affect the business, operations and financial condition of the Company. However, the Company believes that it can adequately address all of the FDA’s concerns without a material impact on the Company’s business. Nonetheless, the Company cannot give any assurance that the FDA will be satisfied with the Company’s response or remedial plan and cannot estimate the date on which these concerns will be resolved, if ever.

Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

These ~~condensed~~ consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States. ~~These~~The ~~condensed~~ consolidated financial statements include the accounts of the Company and its wholly-owned ~~subsidiary, Regeneca International, Inc~~subsidiaries. All intercompany transactions and balances have been eliminated ~~in consolidation~~.

Interim Financial Statements

These interim unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and in accordance with the instructions of the Securities and Exchange Commission (“SEC”) for Form 10-Q. They do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. Therefore, these condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, ~~2009~~2010 filed with the SEC on Form 10-K. The condensed consolidated balance sheet as of December 31, ~~2009~~2010 has been derived from the audited consolidated financial statements ~~filed~~contained ~~with~~in the annual report on Form 10-K for the year ended December 31, ~~2009~~2010.

The condensed consolidated financial statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position, and the results of its operations and cash flows. The results of operations for the period ended September 30, ~~2010~~2011 are not necessarily indicative of the results to be expected for future quarters or the full year.

Use of Estimates

The preparation of these unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to valuation allowances on accounts receivable and inventory, valuation and amortization policies on property and equipment, and valuation allowances on deferred income tax losses. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

~~Accounts~~Cash ~~Receivable~~Equivalents

~~Accounts~~The ~~receivable~~Company ~~are~~considers ~~stated~~all athighly ~~their~~liquid ~~principal balances and are non~~short-~~interest~~term ~~bearing~~investments ~~and~~with ~~unsecured. Management~~maturities ~~conducts a periodic review~~ of ~~the~~less ~~collectability~~than ofthree ~~accounts~~months ~~receivable~~when ~~and~~acquired ~~deems all unpaid amounts greater than 30 days~~ to be ~~past~~cash ~~due~~equivalents. If ~~uncertainty~~The ~~exists~~Company ~~with~~had ~~respect~~no tocash ~~the~~equivalents ~~recoverability~~at ofSeptember ~~certain~~30, ~~amounts~~2011 ~~based~~and onDecember ~~historical experience or economic climate~~31, ~~management will establish an allowance against the outstanding receivables~~2010.

~~Inventory~~Concentration of Credit Risk and Off-Balance Sheet Risk

~~Inventory~~The isCompany ~~comprised~~has ofno ~~raw~~material ~~materials,~~concentrations ~~work-in-progress, and finished goods~~ of ~~its~~credit ~~fuel~~risk, ~~reformulating~~nor ~~products and~~ is ~~recorded~~it ata ~~the~~party ~~lower~~to ofany ~~cost~~financial orinstruments ~~net~~with ~~realizable~~material ~~value~~off-balance onsheet arisk. ~~first~~Financial ininstruments ~~first~~that ~~out~~potentially ~~(FIFO)~~subject ~~basis.~~the ~~The~~ Company ~~establishes inventory reserves for estimated obsolete or unmarketable inventory equal~~ to ~~the~~concentration ~~differences between the cost~~ of ~~inventory~~credit ~~and~~risk ~~the~~consist ~~estimated~~primarily ~~realizable~~of ~~value~~cash ~~based upon assumptions about future~~ and ~~market~~accounts ~~conditions~~receivable. ~~Shipping~~The ~~and~~Company ~~handling~~places ~~costs~~its ~~are~~cash ~~classified~~with asmajor afinancial ~~component of cost of sales in the statement of operations~~institutions.

Reserves for uncollectible amounts are provided, based on past experience and a specific analysis of the accounts. Management determined there was no such allowance necessary at September 30, 2011.

~~Revenue Recognition~~Inventory

~~The~~At ~~Company~~September ~~recognizes~~30, ~~revenue~~2011 ~~from~~and December 31, 2010, inventory consisted of finished goods and is stated at the ~~sale~~lower of ~~its~~cost ~~fuel~~or ~~reformulating~~market. ~~products~~Cost inis ~~accordance~~based ~~with~~on ~~ASC~~the ~~605~~first in, ~~Revenue~~first ~~Recognition~~out method. ~~Revenue~~ isThe ~~recognized~~Company ~~only~~regularly ~~when~~reviews ~~the~~inventory ~~price~~quantities ison ~~fixed~~hand orand, ~~determinable~~when required, ~~persuasive~~provisions ~~evidence~~are ofmade anto ~~arrangement~~reduce ~~exists,~~excess and obsolete inventories to their estimated net realizable value. No such provision was recorded in the ~~service~~nine ismonths ~~provided,~~ended ~~and~~September ~~collectability~~30, is2011 ~~assured~~or 2010.

~~Basic~~Revenue Recognition and ~~Diluted~~Accounts ~~Net Loss Per Share~~Receivable

~~The~~Sales ~~Company~~primarily ~~computes~~represent ~~net~~sales ~~loss~~generated ~~per~~to ~~share~~consumers inand ~~accordance~~independent ~~with~~representatives ~~ASC~~less ~~260,~~any ~~Earnings~~discounts ~~Per~~and ~~Share,~~other ~~which~~deductions. ~~requires~~The ~~presentation~~Company ofrecognizes ~~both~~revenue ~~basic~~upon ~~and~~delivery, ~~diluted~~when ~~earnings~~both ~~per~~title ~~share~~and ~~(EPS) on~~ the ~~face~~risks ofand ~~the~~rewards ~~statement~~ of ~~operations.~~ownership ~~Basic~~pass ~~EPS is computed by dividing net loss available~~ to ~~common shareholders (numerator) by~~ the ~~weighted~~independent ~~average~~representatives. ~~number~~More ofspecifically, ~~shares outstanding (denominator) during~~ the ~~period.~~Company ~~Diluted~~recognizes ~~EPS~~revenues ~~gives~~when ~~effect to~~ all ~~dilutive~~of ~~potential~~the ~~common~~following ~~shares~~conditions ~~outstanding~~exist: a) ~~during~~persuasive ~~the~~evidence ~~period~~of ~~using~~an ~~the~~arrangement ~~treasury~~exists ~~stock~~in ~~method~~the ~~and~~form ~~convertible~~of ~~preferred~~an ~~stock~~accepted ~~using~~purchase ~~the~~order; ~~if-converted~~b) ~~method.~~delivery Inhas ~~computing diluted EPS~~occurred, ~~the~~based ~~average~~on ~~stock~~shipping ~~price~~terms, ~~for~~or ~~the~~services ~~period~~have isbeen ~~used~~rendered; inc) ~~determining~~ the ~~number~~Company’s ofprice ~~shares assumed~~ to ~~be purchased from~~ the ~~exercise~~buyer ofis ~~stock~~fixed ~~options~~ or ~~warrants.~~determinable, ~~Diluted~~as ~~EPS~~documented ~~excludes~~on ~~all~~the ~~dilutive~~accepted ~~potential~~purchase ~~shares~~order; ifand ~~their~~d) ~~effect~~collectibility is ~~anti~~reasonably ~~dilutive~~assured. As atThe ~~March~~Company ~~31,~~provides ~~2010~~for ~~and~~an ~~2009,~~estimated ~~the~~allowance ~~Company~~for ~~had~~sales noreturns ~~potentially~~based ~~dilutive~~on ~~shares~~historical ~~due~~product toreturn ~~its net loss per share~~experience.

Other revenue represents shipping and handling fees billed to consumers and independent representatives.

Stock-based Compensation

The Company records stock-based compensation in accordance with ASC 718, Share-Based Payments, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued.

Derivative Instruments

The Company evaluates free-standing derivative instruments (or embedded derivatives) to properly classify such instruments within equity or liabilities in our consolidated financial statements.

The classification of a derivative instrument is reassessed at each reporting date. If the classification changes as a result of events during a reporting period, the instrument is reclassified as of the date of the event that caused the reclassification. There is no limit on the number of times a contract may be reclassified.

Instruments classified as derivative liabilities are remeasured each reporting period (or upon classification) and the change in fair value is recorded on our consolidated statement of operations in other (income) expense.

Beneficial Conversion Feature of Convertible Notes Payable

The convertible feature of certain notes payable provides for a rate of conversion that is below market value. Such feature is normally characterized as a "Beneficial Conversion Feature" ("BCF"). We measure the estimated fair value of the BCF in circumstances in which the conversion feature is not required to be separated from the host instrument and accounted for separately, and record that value in the consolidated financial statements as a discount from the face amount of the notes. Such discounts are amortized to interest expense over the term of the notes.

Basic and Diluted Loss Per Common Share

Basic loss per common share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted net loss per common share is computed by dividing the net loss by the weighted-average number of common share equivalents outstanding for the period determined using the treasury-stock method if their effect is dilutive. For all periods presented, the effects of all stock-based awards were anti-dilutive due to the net loss incurred and therefore, they were not included in the computation of per share amounts. At September 30, 2011 and December 31, 2010, there were 30,000,000 options to acquire shares of common stock outstanding.

~~Inventory~~License Agreement

AIn ~~summary~~December 2009, the Company entered into a license agreement with Vivakor, Inc. (“Vivakor”), a publicly traded company and related party by way of ~~inventories~~common executive officers, whereby the Company has been granted exclusive worldwide distribution rights to Vivakor’s VivaBoost nutraceutical beverage in the direct-to-consumer market. The Company has agreed to purchase $5,000,000 in product over the initial thirty-six month term and, in the event specified purchase milestones are not met during the initial thirty-six month term, Vivakor has the option to modify or terminate the agreement upon 60 days notice. Upon execution of the license agreement, the Company issued to Vivakor 22,734,236 of its common shares, which were valued at $307,915 and recorded as ~~follows:~~a prepaid license fee. The prepaid license fee is being expensed on a straight-line basis over the initial thirty-six month term of the license agreement. For the three months and nine months ended September 30, 2011 and 2010, the Company recognized amortization expense of $25,660 and $76,980, respectively, which decreased the carrying value of the license to a net total of $122,227 ($102,638 short-term and $19,589 long-term) at September 30, 2011.

		September 30, 2010		December 31, 2009
Raw Materials	$	6,082	$	61,883
Finished Goods		2,607		27,795
	$	8,689	$	89,678

In August 2011, the Company entered into an employment agreement with Dr. Shirish Phulgaonkar whereby Dr. Phulgaonkar would create for the Company a male pro-health formula and a female pro-health formula. The Company will retain the permanent license to these product formulations dependant on attaining sales of 5,000,000 units in the first eighteen months of the agreement. In connection with the development of these formulas, the Company issued Dr. Phulgaonkar 30,000,000 of its common shares, which were valued at $600,000 based on the Company’s common stock trading price at time of issuance, and recorded as a prepaid license fee. The prepaid license fee is being expensed on a straight-line basis over the estimated useful life of the product of five years, subject to any required review for impairment. For the three months ended September 30, 2011, the Company recognized amortization expense of $17,096, which decreased the carrying value of the license to a net total of $582,904 ($120,000 short-term and $462,904 long-term) at September 30, 2011.

Other Assets

AsIn atFebruary ~~September 30~~2011, ~~2010~~the Company entered into a two-year agreement with Goal Capital for investor relations consulting services. In connection with the agreement, ten million shares of the Company’s ~~had~~common ~~security~~stock ~~deposits~~were issued to Goal Capital. The shares were valued at a total of $12450,~~500~~000 ~~relating~~based toon the ~~Company’s~~current ~~property~~stock price of $0.045 per share which was recorded as a prepaid asset. In the three months and ~~equipment~~nine months ended September 30, 2011, $56,250 and $150,000 was recorded as compensation expense, respectively, which decreased the carrying value of the prepaid asset to $300,000 at September 30, 2011.

Convertible Notes Payable

AtIn ~~September~~the 30three months ended March 31, ~~2010~~2011, the Company ~~owed~~issued $1,~~150~~122,~~000~~500 toof aconvertible ~~third~~promissory ~~party~~notes. ~~under~~Under anthe ~~unsecured~~terms ~~promissory~~of the note agreements, ~~bearing~~each note is due interest at 1012% per annum, ~~and~~secured by the Company’s assets, due onin ~~demand~~two years from the date of issuance. At ~~September~~The 30notes, ~~2010~~along with any accrued interest, shall be convertible into common shares of the Company ~~owed~~at ~~$106,250~~the option of ~~accrued~~the ~~interest~~note ~~under~~holder at the lesser of 1) $0.025 per share or 2) 90% of such ~~note~~common stock’s fair market value. ~~Such~~The ~~note~~notes ~~was~~contain ~~subsequently~~"anti-dilution" ~~exchanged~~protection, such that if the Company issues and sells common stock, or securities convertible into or exercisable for ~~shares~~common stock of the Company, at a price per share that is less than the applicable Conversion Price, then the Conversion Price is adjusted downward to match such lower issuance price. On these notes, a debt discount was recorded of approximately $905,500 related to management’s ~~common~~determination ~~stock~~that under ASC 815, the anti-dilution features of the notes resulted in ~~connection~~a ~~with~~derivative liability. Using a binomial lattice valuation model, management determined that the ~~Merger~~derivative fair value was $905,500 upon issuance of such notes. Accordingly, management recorded a liability of $905,500 and a debt discount of equal amount.

AtIn ~~September~~the three months ended June 30, ~~2010~~2011, the Company ~~owed~~issued $~~500~~1,015,000 toof ~~another~~convertible ~~third~~promissory ~~party~~notes. ~~under~~Under anthe ~~unsecured~~terms ~~promissory~~of the note ~~bearing~~agreements, each note is due interest at 1012% per annum, secured by the Company’s assets, due in two years from the date of issuance. ~~Related~~ The notes, along with any accrued interest, ~~approximated~~shall be convertible into common shares of the Company at the option of the note holder at the lesser of 1) $870.025 per share or 2) 90% of such common stock’s fair market value. The notes contain "anti-dilution" protection,~~500~~ atsuch ~~September~~that 30if the Company issues and sells common stock, ~~2010. Such~~or ~~note~~securities ~~was~~convertible ~~subsequently~~into ~~exchanged~~or exercisable for ~~shares~~common stock of the Company, at a price per share that is less than the applicable Conversion Price, then the Conversion Price is adjusted downward to match such lower issuance price. On these notes, a debt discount was recorded of approximately $763,500 related to management’s ~~common~~determination ~~stock~~that under ASC 815, the anti-dilution features of the notes resulted in ~~connection~~a ~~with~~derivative liability. Using a binomial lattice valuation model, management determined that the ~~Merger~~derivative fair value was $763,500 upon issuance of such notes. Accordingly, management recorded a liability of $763,500 and a debt discount of equal amount.

At September 30, 2010, the Company owed $250,000 to another third party under an unsecured promissory note, bearing interest at 12% per annum, and due on demand. Related accrued interest approximated $51,842 at September 30, 2010. Such note was subsequently exchanged for shares of the Company’s common stock in connection with the Merger. 10

AtIn the three months ended September 30, ~~2010~~2011, the Company ~~owed~~issued $50400,000 toof aconvertible ~~third~~promissory ~~party~~notes. ~~under~~Under anthe ~~unsecured~~terms ~~promissory~~of the note agreements, ~~bearing~~each note is due interest at 108% per annum, ~~and~~secured by the Company’s assets, due onin ~~demand~~two years from the date of issuance. At ~~September~~The 30notes, ~~2010~~along with any accrued interest, shall be convertible into common shares of the Company ~~owed~~at ~~$5,805~~the option of ~~accrued~~the ~~interest~~note ~~under~~holder at the lesser of 1) $0.025 per share or 2) 90% of such ~~note~~common stock’s fair market value. ~~Such~~ ~~note~~The ~~was~~notes ~~subsequently~~contain ~~exchanged~~"anti-dilution" protection, such that if the Company issues and sells common stock, or securities convertible into or exercisable for ~~shares~~common stock of the Company, at a price per share that is less than the applicable Conversion Price, then the Conversion Price is adjusted downward to match such lower issuance price. On these notes, a debt discount was recorded of approximately $70,000 related to management’s ~~common~~determination ~~stock~~that under ASC 815, the anti-dilution features of the notes resulted in ~~connection~~a ~~with~~derivative liability. Using a binomial lattice valuation model, management determined that the ~~Merger~~derivative fair value was $70,000 upon issuance of such notes. Accordingly, management recorded a liability of $70,000 and a debt discount of equal amount.

Significant assumptions used in such valuation include:


	Three months ended September 30, 2011
Expected life	2 years
Estimated volatility	35.07%
Risk-free interest rate	0.18% – 0.37%
Expected dividends	None

In the three months and nine months ended September 30, 2011, the Company recognized interest expense of $679,248 and $946,546, respectively, related to such notes. The balance of convertible notes payable is shown net of unamortized discounts in the accompanying condensed consolidated balance sheet.

Below is a table summarizing the Company’s balances as of September 30, 2011 related to its convertible notes payable:


	Issue Date	Face Amount	Unamortized Discount	Net Amount	Fair Value of Convertible Option – Derivative Value
1)	12/20/2010	$120,000	$33,685	$86,315	$18,895
2)	12/29/2010	130,000	37,175	92,825	20,725
3)	1/28/2011	100,000	45,377	54,623	15,180
4)	2/9/2011	75,000	39,393	35,607	11,598
5)	2/23/2011	375,000	224,302	150,698	59,034
6)	3/9/2011	72,500	36,510	35,990	11,589
7)	3/11/2011	25,000	14,779	10,221	4,004
8)	3/16/2011	200,000	118,243	81,757	32,194
9)	4/7/2011	150,000	119,296	30,704	21,235
10)	4/22/2011	100,000	56,815	43,185	15,218
11)	5/18/2011	325,000	145,934	179,066	53,108
12)	7/15/2011	50,000	7,294	42,706	8,064
13)	8/16/2011	100,000	15,627	84,373	17,257
14)	8/23/2011	100,000	18,152	81,848	17,439
15)	8/31/2011	100,000	17,073	82,927	17,632
16)	9/20/2011	50,000	8,058	41,942	9,031
		$2,072,500	$937,713	$1,134,787	$332,203

During the three months ended September 30, 2011, $815,000 of convertible notes payable principal and $30,878 of accrued interest was converted into 45,731,617 common shares of the Company.

For the three and nine months ended September 30, 2011, the change in the estimated fair value of derivative liability resulted in a gain of $702,503 and $1,395,013, respectively, and is included in other income in the accompanying condensed consolidated statements of operations.

~~Convertible~~Advances ~~Debentures~~Payable to Related Parties

OnAdvances ~~August~~payable 3,to ~~2009,~~related ~~the~~parties ~~Company~~are ~~issued~~noninterest ~~units~~bearing ~~(the~~and ~~“August~~represent ~~Units”)~~cash ofadvances ~~convertible~~directly ~~promissory~~to ~~notes. Under~~ the ~~terms of the note agreement, each August Unit is comprised of a $100,000 convertible note, due interest at 12% per annum, secured by the~~ Company’s ~~assets,~~as ~~and~~well ~~due~~as ~~in two years from the date of issuance, and convertible into common shares of the~~ Company atexpenditures ~~the~~that ~~option~~were ofpaid ~~the~~for ~~note~~directly ~~holder~~by ~~at a fixed conversion rate of $0.225 per common share. Furthermore, each August Unit includes 100,000 share purchase warrants, where each warrant allows~~ the ~~warrant~~related ~~holder~~parties toon ~~purchase~~behalf ~~one additional common share~~ of the Company ~~at a fixed rate $0.30 per common share~~ for awhich ~~period of three years from~~ the ~~date~~related ofparties ~~issuance. Such~~have ~~note~~not ~~was~~been ~~exchanged for shares of the Company’s common stock in connection with the Merger~~reimbursed. At ~~September~~These ~~30,~~advances ~~2010,~~are ~~the~~unsecured ~~Company has recognized accretion expense of $61,796, which is included in depreciation~~ and ~~amortization~~came ~~expense~~from indirectors ~~the statement of operations~~ and ~~increased~~officers ~~the carrying value~~ of the ~~August Units to $115,538~~Company.

From November 2008 to June 2009, the Company issued units (the “12% Units”) of convertible promissory notes. Under the terms of the note agreement, each 12% Unit is comprised of a $50,000 convertible note due interest at 12% per annum, secured by the Company’s assets, and due in two years from the date of issuance, and convertible into common shares of the Company at the option of the note holder at a fixed conversion rate of $0.25 per common share. Furthermore, each 12% Unit includes 100,000 share purchase warrants, where each warrant allows the warrant holder to purchase one additional common share of the Company at a fixed rate of $0.25 per common share for a period of three years from the date of issuance. Such note was exchanged for shares of the Company’s common stock in connection with the Merger. At September 30, 2010, the Company has recognized accretion expense of $307,333, which is included in depreciation and amortization expense in the statement of operations and increased the carrying value of the remaining 12% Units to $463,049. 11

On May 11, 2009, the Company issued units (the “10% Units”) of convertible promissory notes. Under the terms of the note agreement, each 10% Unit is comprised of a $25,000 convertible note due interest at 10% per annum, secured by the Company’s assets, and due in two years from the date of issuance, and convertible into common shares of the Company at the option of the note holder at a fixed conversion rate of $0.40 per common share. Furthermore, each 10% Unit includes 50,000 share purchase warrants, where each warrant allows the warrant holder to purchase one additional common share of the Company at a fixed rate of $0.40 per common share for a period of three years from the date of issuance. Such note was exchanged for shares of the Company’s common stock in connection with the Merger. At September 30, 2010, the Company has recognized accretion expense of $10,451, which is included in depreciation and amortization expense in the statement of operations and increased the carrying value of the 10% Units to $16,255.

On January 9, 2009, the Company terminated a $300,000 unsecured promissory note that bore interest at 10% per annum and was due on February 11, 2009 and replaced it with a new $550,000 promissory note that was unsecured, bore interest at 10% per annum, and was due on September 30, 2009. Such note was converted to shares of the Company’s common stock as a result of the Merger. At September 30, 2010, the Company owed $78,503 of accrued interest on such note.

~~Common~~Stock ~~Shares~~Incentive Plan

~~All~~On ~~common~~December ~~shares~~31, ~~issued~~2010, ~~for~~the ~~non-cash~~Company ~~purposes~~adopted ~~have~~the ~~been~~2010 ~~valued~~Stock ~~using~~Incentive Plan, pursuant to which the ~~end-~~Company is authorized to issue up to 20% of~~-day~~ ~~trading~~its ~~price~~outstanding onshares ~~the~~of ~~over-the-counter~~common ~~bulletin~~stock ~~board~~to ~~(OTCBB)~~its onemployees, executives and consultants. On December 31, 2010, the ~~date~~Company ofissued ~~issuance~~certain employees, executives, and consultants 30,000,000 options to purchase Company common stock at $0. 025 per share, with vesting ranging from 2 years to 3 years. At September 30, 2011, there were 212,000,000 shares available for future grants under the plan.

NoThe ~~shares~~Company ~~were~~recorded ~~issued~~compensation costs related to options granted under the 2010 Incentive Plan of $35,415 and $106,245 during the ~~quarter~~three months and nine months ended September 30, ~~2010.~~ 2011, respectively, and total unrecognized compensation costs related to nonvested options as of September 30, 2011 amounted to $263,755 and, assuming the grantees continue to be employed by or remain as directors of the Company, such amount will be recognized as compensation expense as follows:


Years ending December 31,
2011 (remainder of year)	$	35,422
2012		141,667
2013		86,666

	$	263,755

There was no stock option activity during the nine months ended September 30, 2011.

~~Share~~Commitments ~~Purchase~~and ~~Warrants~~Contingencies

~~During~~Operating ~~the nine months ended September 30, 2010, the Company did not issue any share purchase warrants. Warrants outstanding at September 30, 2010 can be summarized as follows:~~ Leases

		Number of Warrants	Weighted Average Exercise Price $	Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
Balance – December 31, 2008		3,400,000	1.55
	Granted	3,125,000	0.25
	Granted	150,000	0.40
	Granted	200,000	0.30
	Cancelled	(1,500,000)	(0.35)
Balance – December 31, 2009		5,375,000	1.05	1.94	–
Balance – September 30, 2010		5,375,000	1.05	1.19	–

The Company leases approximately 8,700 square feet of office space under a lease due to expire on April 30, 2016. Rent expense totaled $74,806 and $28,017 in the nine months ended September 30, 2011 and 2010, respectively.

AtAs of September 30, ~~2010~~2011, the ~~following~~Company’s ~~share~~future ~~purchase~~annual ~~warrants~~minimum ~~were~~lease ~~outstanding~~payments are as follows:

Number of Warrants	Exercise Price	Expiry Date
		Amount
1,900,000	$2.50	May 23, 2010
2011 (remainder of year)	$	23,481
400,000	$0.25	January 1, 2012
2012		90,448
200,000	$0.25	January 8, 2012
2013		97,404
200,000	$0.25	February 19, 2012
2014		102,624
100,000	$0.25	March 9, 2012
Thereafter		145,452
100,000	$0.25	April 1, 2012
	$	459,409
625,000	$0.25	April 21, 2012
50,000	$0.40	May 11, 2012
100,000	$0.40	May 14, 2012
200,000	$0.30	August 5, 2012
1,500,000	$0.25	January 9, 2014
5,375,000

Legal

The Company may be involved from time to time in various claims, lawsuits, disputes with third parties, actions involving allegations or discrimination or breach of contracts actions incidental to the normal course of operations. Other than what is disclosed below, the Company is currently not involved in any such litigation that management believes could have a material adverse effect on its financial position or results of operations.

The Company is presently involved in the following material pending legal proceedings not incidental to the business of the Company:

In March 2009, a lawsuit was filed in the United States District Court, District of Utah, Central Division, against the Company by Republic Bank. The lawsuit alleged that the Company breached the terms of a Lease Agreement involving Mazuma Capital Corp. and the Company. Republic Bank sought monetary damages and return of certain equipment. On February 9, 2011, Summary Judgment was entered in favor of Republic Bank. Subsequently, the Company and Republic Bank finalized the terms of a settlement agreement during the 2nd quarter of 2011. The terms of the settlement are the forfeiture of the security deposit on the lease, the leased property, and payments totaling $200,000. The Company was indemnified by a group of stockholders against claims originating before the Merger, and as of December 1, 2011 such stockholders have paid approximately $150,000 and are obligated to make monthly payments of $8,791 per month per month for six more months. If not paid by such stockholders, the Company would still be obligated to pay Republic Bank and then pursue its claim for indemnification against the stockholders.

In March 2011, a lawsuit was filed in the Superior Court of California, County of San Diego, South County Division against the Company by Frederick Chorney. The lawsuit alleges that the Company breached the terms of a consulting agreement between the Company and Mr. Chorney. Mr. Chorney is seeking monetary damages in the amount of $150,000. Mr. Chorney has requested a jury trial which is currently in the discovery stage. The Company, based on advice from counsel, cannot provide assurances as to the outcome of this matter.

~~Stock~~Equity ~~Options~~Transactions

During the nine months ended September 30, ~~2010~~2011, the Company ~~did~~issued ~~not~~4,000,000 ~~issue any stock options. Options to purchase~~ common ~~stock~~shares ~~can~~for becash ~~summarized~~proceeds asof ~~follows at September 30~~$100, ~~2010:~~000.

		Number of Options	Weighted Average Exercise Price $	Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
Balance – December 31, 2008		2,400,000	0.22
	Granted	7,500,000	0.25
	Cancelled	(7,500,000)	(0.25)
Balance – December 31, 2009		2,400,000	0.22	3.67	–

10.

Commitments and Contingencies

In October 2007, the Company completed a sale and leaseback agreement with respect to its building. Commencing November 1, 2007, the Company entered into a 15-year lease agreement, with monthly lease payments of $63,000, to a company controlled by directors of the Company. During the nine months ended September 30, 2010, the Company incurred lease payments of $567,000. As a condition of the Merger, the lease agreement was terminated prior to the effective date of such Merger without any further payments or obligations due thereunder.

11.

Subsequent Events

Management has evaluated events subsequent to September 30, ~~2010~~2011 through the date that the accompanying condensed consolidated financial statements were filed with the Securities and Exchange Commission for transactions and other events which may require adjustment of and/or disclosure in such financial statements.

~~Subsequent~~In toOctober ~~September 30~~2011, ~~2010,~~ the Company issued ~~846~~2,~~693~~800,~~731~~000 ~~shares of its~~ common ~~stock~~shares inwith ~~the~~a ~~aggregate~~fair ~~for~~value ~~consulting~~of ~~services~~$42,000 toin ~~settle~~connection ~~outstanding~~with ~~debt,~~convertible ~~and~~notes ~~pursuant~~payable toissued ~~various~~in ~~agreements~~October 2011, ~~including~~in ~~the~~accordance ~~transaction~~ with ~~Regeneca as more specifically reported on~~ the ~~Company’s~~terms ~~current~~of ~~report~~conversion onin ~~Form 8-K as filed with~~ the ~~SEC on January 4, 2011~~notes.

OnIn ~~May~~October 312011, ~~2010,~~ the Company ~~and~~issued ~~AL Global Corporation~~500,000 acommon ~~California~~shares ~~corporation~~with ~~(d.b.~~a. ~~Youngevity)~~fair ~~("Youngevity")~~value ~~agreed~~of to$7,500 ~~terminate~~for ~~the~~services ~~Agreement~~rendered, ~~and~~valued ~~Plan~~at of$.015 ~~Merger~~per ~~entered~~share ~~into~~based on ~~November~~the ~~21,~~Company’s ~~2009~~common ~~providing~~stock ~~for~~trading price at the ~~acquisition~~time of ~~Youngevity by the Company~~issuance.

~~Effective~~In ~~May~~November 312011, ~~2010,~~ the Company ~~accepted~~issued ~~the~~3,267,974 ~~resignations~~common ofshares ~~both~~for ~~Mr.~~cash ~~Joel~~proceeds ~~D. Wallach as Chairman~~ of ~~the~~$50,000, ~~Board~~at ~~of Directors and Mr~~$.015 ~~Stephan~~per Rshare. ~~Wallach as the Chief Executive Officer, President and Secretary.~~

OnIn December ~~31,~~ ~~2010~~2011, ~~the Company and Regeneca International, Inc~~Dr. ~~entered~~Shirish ~~into~~Phulgaonkar anresigned ~~Agreement~~from ~~and~~his ~~Plan~~position ofas ~~Merger~~Chief ~~(“Merger~~Scientific ~~Agreement”),~~Officer ~~pursuant to which EEI Acquisition Corporation, Inc., a wholly-owned subsidiary~~ of the Company, ~~merged~~citing ~~with~~personal and ~~into~~health ~~Regeneca~~reasons. As a result of the Merger between Regeneca International, Inc. and the Company, all of Regeneca International’s common stock was converted into approximately 420,466,422 shares of the Company’s common stock that represented approximately fifty-one percent (51%) of the outstanding shares of the Company, on a fully diluted basis, immediately after the Merger.

As of December 31, 2010, Bruce Tackmann resigned as the only officer and director of the Company. Matthew Nicosia, Adam Vincent Gilmer, Jan Hall, Francis Chen and James C. Short were appointed as directors of the Company (with Francis Chen being the Chairman of the Board). Matthew Nicosia, Adam Vincent Gilmer, Daniel R. Kerker and Christopher A. Wilson were appointed as the Chief Executive Officer, President, Chief Financial Officer/Treasurer and Secretary, respectively. 13

On December 31, 2010, the Company entered into an Employment Agreement with Matthew Nicosia who shall serve as the Chief Executive Officer of the Company for a term of two (2) years in exchange for a base salary of two hundred seventy-five thousand dollars ($275,000).

On December 31, 2010, the Company entered into an Employment Agreement with Adam Vincent Gilmer who shall serve as the President of the Company for a term of two (2) years in exchange for a base salary of two hundred seventy thousand dollars ($270,000). On August 19, 2011, the Company’s Board of Directors terminated Adam Vincent Gilmer as President of the Company, and Matt Nicosia, the Company’s CEO, assumed the duties of President.

On December 31, 2010, the Company entered into an Employment Agreement with James C. Short who shall serve as the Vice President of Investor Relations for the Company for a term of two (2) years in exchange for a base salary of one hundred twenty thousand dollars ($120,000).

On December 31, 2010, the Company entered into an Employment Agreement with Daniel R. Kerker who shall serve as the Chief Financial Officer of the Company in exchange for base salary of two hundred twenty thousand dollars ($220,000).

On December 31, 2010, the Company adopted the 2010 Equity Incentive Plan, subject to shareholder approval, pursuant to which the Company is authorized to issue up to 20% of its outstanding shares of common stock to its employees, executives and consultants.

On March 2, 2011, the Company entered into a License Agreement with Mitch Huhem and One Step Millionaire, LLC (collectively, “Licensor”), whereby the Licensor granted to the Company a perpetual, royalty-bearing, exclusive, worldwide, transferable, sublicensable license to the One Step Millionaire program (“Licensed Product”) to formulate, design, develop, improve, produce, distribute, sell and use and exploit the Licensed Product for a period of twenty (20) years.

On May 6, 2011, each of Francis W. Chen and Jan Hall, directors of the Company, resigned from their position on the Board of Directors.

On June 10, 2011, the Company reached a settlement agreement with Republic Bank resulting from a lease agreement it had defaulted on with Mazuma Capital Corp. for equipment. Republic Bank had been awarded a judgment in excess of $400,000. The settlement agreement provided that the Company would forfeit its security deposit on the lease of approximately $400,000, the leased equipment itself, and make additional payments totaling $200,000. The Company was indemnified by a group of shareholders against claims originating prior to the Merger, and as of September 1, 2011 such shareholders had made payments in excess of $117,000. As a result, the Company did not record any accrual related to this matter as of September 30, 2010. The balance is payable $8,791 per month until paid in full.

ITEM 2.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION OR PLAN OF OPERATION

FORWARD-LOOKING STATEMENTS

This Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) contains forward-looking statements that involve known and unknown risks, significant uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, or implied, by those forward-looking statements. You can identify forward-looking statements by the use of the words may, will, should, could, expects, plans, anticipates, believes, estimates, predicts, intends, potential, proposed, or continue or the negative of those terms. These statements are only predictions. In evaluating these statements, you should consider various factors which may cause our actual results to differ materially from any forward-looking statements. Although we believe that the exceptions reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

BUSINESS

The Company’s business strategy is a hybrid model combining the best of network marketing and direct response marketing. The Company pre-launched its network marketing activities in February 2011 along with the launch of its male enhancement product RegenErect^TM. The Company launched its direct response marketing activities in the second quarter of 2011, as well as its appetitie control product RegeneSlim^TM. The Company officially launched its entire functional business model, including both network marketing and direct response marketing, in November 2011.

The Company drives customer acquisition through direct response marketing channels, such as television and radio, while concurrently developing a customer base and sales organization that stretches across the United States and, eventually, the globe. The Company’s customer acquisition activities support the efforts of the network marketing organization by providing customers and creating brand recognition.

Subsequent Events

This Quarterly Report on Form 10-Q for the period ended September 30, ~~2010~~2011 is being filed with the Securities and Exchange Commission on or about ~~September~~December 1320, 2011. Due to the delay in filing this report, amanagement ~~number~~has ofevaluated ~~material~~events subsequent to September 30, 2011 and has concluded that no events have occurred ~~since~~that ~~September~~require ~~30,~~recognition ~~2010. These~~or ~~events~~disclosure ~~include:~~in this report.

Regeneca International, Inc. (“Regeneca International”) has merged into a subsidiary of the Company and the former shareholders of Regeneca International were issued shares of Company common stock representing a majority of the outstanding shares (see Current Report on Form 8-K filed on January 4, 2011).

In connection with the merger, the Company has adopted the business plan and product offerings of Regeneca International as its primary business focus. The Company does not expect sales of the products described in this report to be material to the sales and revenue of the Company in the foreseeable future.

The former officers and directors of Regeneca International became the officers and directors of the Company.

The Company has adopted the 2010 Incentive Plan and the Distributor Stock Incentive Plan (see the Definitive Information Statement on Form 14C filed on May 24, 2011).

On June 10, 2011, the Company reached a settlement agreement with Republic Bank resulting from a lease agreement it had defaulted on with Mazuma Capital Corp. for equipment. Republic Bank had been awarded a judgment in excess of $400,000. The settlement agreement provided that the Company would forfeit its security deposit on the lease of approximately $400,000, the leased equipment itself, and make additional payments totaling $200,000. The Company was indemnified by a group of shareholders against claims originating prior to the Merger, and as of September 1, 2011 such shareholders had made payments in excess of $117,000. The balance is payable $8,791 per month until paid in full.

Although being prepared and filed in September 2011, this report describes the products and business strategy of the Company as at September 30, 2010, and does not reflect any of the material changes that have occurred since such date. Portions of this report are derived from materials prepared by the former officers and directors of the Company and contain descriptions of, and statements of fact regarding, products, strategies and projections of which the current officers and directors have no personal knowledge. The Company believes that much of the contents of this report have been superseded by subsequent events, and readers should not place undue emphasis on the disclosure and information contained herein.

RESULTS OF OPERATIONS

Operating Revenues

During the three and nine months ~~periods~~ ended September 30, ~~2010~~2011, the Company recognized revenues of $90403,~~278~~700 and $~~378~~2,~~284~~475,536 compared with $~~417~~13,~~381~~474 and $182,~~026,685~~456 for the three and nine months ended September 30, ~~2009~~2010, respectively. The operating revenues are comprised primarily of sales of the Company’s ~~Ethos~~RegenErectTM ~~FR®~~and ~~product~~RegeneSlimTM products. Other components of revenue include freight and service. The ~~decrease~~increase in revenues is attributable to the ~~fact~~change ~~that~~in the Company’s ~~had~~business ~~limited~~strategy, ~~cash~~the ~~flows~~introduction toof ~~fund~~RegenErect ~~selling~~and RegeneSlim, and the pre-launch of the Company’s networking marketing ~~expenses~~program in February 2011. Revenues for the three months ended September 30, 2011 were lower than previous quarters due to the discontinuation and subsequent returns of our second formulation of RegenErect in mid-August 2011. The Company began shipment of its new formulation of RegenErect which was developed by Dr. Shirish Phulgaonkar in late September 2011.

Operating Expenses and Net Loss

Operating expenses for the three and nine months ended September 30, ~~2010~~2011 were $~~292~~1,~~657~~180,092 and $15,~~199~~549,~~217~~177 and are comprised of costs associated with general and administrative costs such as staff salaries, consulting, marketing, and legal and accounting, and selling expenses such as marketing and business development, specifically the marketing costs associated with the increased advertising and media expenses surrounding the launch of RegenErectTM and RegeneSlimTM and launch of the Company’s direct response marketing program. Operating expenses for the three months ended September 30, 2011 were lower than previous quarters due to the concentration on the development of the Company’s new formulation of RegenErect and a reduction in general and marketing expenditures compared with previous quarters.

Operating expenses for the three and nine months ended September 30, 2009 were $900,965 and $4,328,737 and are comprised of costs associated with general and administrative costs such as staff salaries, consulting, marketing, and legal and accounting, and selling expenses such as marketing and business development.14

~~For~~Operating expenses for the three and nine months ended September 30, 2010, ~~the~~were ~~Company incurred net losses of~~ $~~332~~501,~~638~~443 and $1974,~~251,976~~376 ~~compared~~and ~~with~~are ~~net~~comprised ~~losses~~ of ~~$838,449~~costs ~~and~~associated ~~$4,128,814~~with ~~for~~general ~~the~~and ~~three~~administrative ~~and~~costs ~~nine~~such ~~months~~as ~~ended~~staff ~~September~~salaries, 30consulting, ~~2009.~~marketing, ~~The~~and ~~decrease~~legal inand ~~net loss is due to the effects of the stock-based compensation expense of $483~~accounting,~~266~~ ~~in 2009~~ and ~~decreases in~~ selling ~~and marketing~~ expenses ~~due~~such toas ~~the~~marketing ~~Company~~and ~~having~~business ~~limited cash flows in the first nine months of 2010~~development.

Other expense for the three months ended September 30, 2011 totaled $42,825. This total includes again recorded for the change in value of the derivative liability associated with the Company’s convertible notes payable of $702,503, as well as the accretion of the related debt discount totaling $679,248 which was recorded as interest expense.

For the three and nine months ended September 30, 2011, the Company incurred a net loss of $888,400 and $3,349,778 compared with a net loss of $490,948 and $903,708 for the three and nine months ended September 30, 2010, respectively. The increase in net loss for the nine month period is due to increased marketing expenses related to the introduction of RegenErect^TM and RegenSlim^TMand the launch of the Company’s direct response marketing program. In the three months ended September 30, 2011, the net loss was lower than previous quarters due to a reduction in operating expenses as well as a gain of $702,503 on the change of value of the derivative liability from the Company’s convertible notes payable.

LIQUIDITY AND CAPITAL RESOURCES

Working Capital

		September 30, 2010		September 30, 2009
	September 30, 2011	September 30, 2010
Current Assets	$ 1,271,803	89$ 311,~~294~~667	$	~~243,617~~
Current Liabilities	3,031,853	4273,535~~,387~~		~~3,549,645~~
Working Deficit	$	(4,446,093)	$	(3,306,028)
Working (Deficit) Capital	$ (1,760,050)	$ 38,132

Cash Flows

	For the nine months ended	~~For the nine months ended~~
		September 30, 2010		September 30, 2009
	September 30, 2011	September 30, 2010
Cash Flows used in Operating Activities	$ (2,391,733)	$ (~~487~~73,~~728~~156)	$	~~(1,454,034)~~
Cash Flows from Financing Activities		200,000		1,469,686
Cash Flows used in Investing Activities	(8,739)	(2,500)
Net (decrease) increase in Cash During Period	$	(287,728)	$	15,622
Cash Flows from Financing Activities	2,637,500	128,550
Net Increase in Cash During Period	$ 237,028	$ 52,894

AsAt at September 30, ~~2010~~2011, the Company had cash of $60453,~~226~~504, current assets of $891,~~294~~271,803, total assets of $~~108~~1,~~839~~836,821, total liabilities of $43,~~535~~031,~~387~~853, and a stockholders’ deficit of $41,~~426~~195,~~548~~032.

AsAt at September 30, ~~2010~~2011, the Company had anegative working capital ~~deficit~~ of $41,~~446~~760,~~093~~050 compared with a working capital ~~deficit~~ of $338,~~306,028~~132 as at September 30, ~~2009~~2010. The ~~increase~~decrease in working capital ~~deficit~~ was attributed to the fact that the Company had ~~limited~~higher ~~cash~~accrued ~~flows~~liabilities due to ~~fund~~its ~~operations~~expanded ~~and~~operating ~~inventory and~~expenses, ~~therefore,~~as ~~has~~well ~~been~~as ~~unable~~liabilities related to ~~generate~~its ~~positive~~convertible ~~earnings~~notes ~~from~~payable ~~operations~~and derivative liabilities.

Cash Flows from Operating Activities

During the nine months ended September 30, ~~2010~~2011, the Company used $~~487~~2,~~728~~391,733 of cash for operating activities compared to the use of $173,~~454,034~~156 of cash ~~for~~from operating activities during the nine months ended September 30, ~~2009~~2010. The change in net cash used in operating activities is attributed to the fact that the Company ~~had~~was ~~scaled~~launching ~~down~~RegenErectTM ~~operations~~and inRegeneSlimTM ~~2010~~and ~~compared~~its tonetwork ~~2009~~marketing ~~due~~and todirect ~~having~~response ~~limited~~programs ~~access~~in tothe ~~cash~~nine tomonths ~~fund~~ended ~~operations~~September 30, 2011.

Cash Flows from Financing Activities

During the nine months ended September 30, ~~2010~~2011, the Company received $~~200~~2,~~000~~637,500 of cash from financing activities compared to $1128,~~469,686~~550 for the nine months ended September 30, ~~2009~~2010. The change in cash flows from financing activities is attributed to the fact that the Company ~~did~~issued ~~not~~notes ~~issue~~payable asin ~~many~~the ~~due~~nine onmonths ~~demand~~ended ~~notes~~September ~~and~~30, ~~convertible~~2011 ~~promissory~~in ~~notes~~order asto itfund ~~had during~~ the ~~previous~~Company’s ~~period~~expanded operations.

Going Concern

WeThe ~~have~~Company does not ~~attained~~have ~~profitable~~sufficient ~~operations~~cash on hand to fund its administrative and ~~are~~other operating expenses or its proposed sales and marketing programs for the next twelve months. During the first nine months of 2011, the Company has issued $2,587,500 in convertible promissory notes in exchange for cash to fund operations. The Company’s ability to become a profitable operating company is dependent upon obtaining financing adequate to ~~pursue~~fulfill ~~any~~its ~~extensive~~market ~~acquisitions~~introduction activities, and ~~activities~~achieving a level of revenues adequate to support the Company’s cost structure. ~~For~~Management ~~these~~intends ~~reasons~~to finance the Company’s operations from loans and advances from current stockholders, ~~our~~future ~~auditors~~public ~~stated~~and inprivate ~~their~~debt ~~report~~and onequity ~~our~~offerings ~~2009~~and ~~audited~~proceeds ~~financial~~from ~~statements~~product ~~that~~sales. ~~they~~However, ~~have~~there ~~substantial~~can ~~doubt~~be no assurance that weadditional capital will be ~~able~~available, which may affect the Company’s ability to continue as a going concern. ~~without~~The ~~further~~accompanying ~~financing.~~financial ~~Furthermore,~~statements asdo anot ~~result~~include ofany adjustments to reflect the ~~merger~~possible ~~with~~future ~~Regeneca~~effects ~~International,~~on the ~~Company~~recoverability ~~has~~and ~~ceased~~classification ~~manufacturing~~of ~~and~~assets ~~distributing~~or the ~~products~~amounts and classification of ~~Ethos~~liabilities ~~Environmental~~that ~~offered~~may ~~during~~result from the ~~quarter~~possible ~~ended~~inability ~~September~~of ~~30,~~the ~~2010~~Company to continue as a going concern.

OFF-BALANCE SHEET ~~ARRANGEMENTS~~ARRANGEMENT

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

CRITICAL ACCOUNTING POLICIES

Our financial statements and accompanying notes have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis. The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

We ~~regularly~~believe ~~evaluate~~that the ~~accounting~~estimates ~~policies~~ and ~~estimates~~assumptions that weare ~~use~~most important to ~~prepare~~the portrayal of our financial ~~statements.~~condition Aand ~~complete~~results ~~summary~~ of ~~these~~operations, ~~policies~~in isthat ~~included~~they inrequire the ~~notes~~most difficult, subjective or complex judgments, form the basis for the accounting policies deemed to ~~our~~be ~~financial~~most ~~statements~~critical to us. InThese ~~general,~~critical ~~management's~~accounting ~~estimates~~policies ~~are~~relate ~~based~~to onbeneficial ~~historical~~conversion ~~experience~~feature of convertible notes payable, ~~information~~impairment ~~from~~of ~~third~~long ~~party~~lived ~~professionals~~assets, stock compensation, and ~~various~~evaluation ~~other~~of ~~assumptions~~contingencies. ~~that~~We ~~are~~believe ~~believed~~estimates and assumptions related to bethese ~~reasonable~~critical accounting policies are appropriate under the ~~facts~~circumstances; ~~and~~however, ~~circumstances.~~should ~~Actual~~future ~~results~~events or occurrences result in unanticipated consequences, there could ~~differ~~be ~~from~~a ~~those~~material ~~estimates~~impact ~~made~~on byour ~~management~~future financial condition or results of operations.

There have been no changes to our critical accounting policies as disclosed in our Form 10-K for the year ended December 31, 2010.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by our company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management carried out an evaluation under the supervision and with the participation of our Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 ("Exchange Act"). Based ~~upon~~on that evaluation, our ~~Principal~~Chief Executive Officer and ~~Principal~~Chief Financial Officer ~~have~~ concluded that our disclosure controls and procedures were not effective asbased ofon ~~September~~our ~~30,~~material ~~2010,~~weakness ~~due~~in to the ~~material~~form ~~weaknesses~~of ~~resulting~~lack ~~from~~of ~~our~~segregation ~~inability~~of toduties, ~~timely~~which ~~file~~stems ~~our~~from ~~Form 10-Q’s and 10-K’s. Additionally,~~ our ~~controls~~early ~~were~~stage ~~not~~status ~~designed~~ and inlimited ~~place~~capital resources to ~~ensure~~hire ~~that~~additional ~~all~~financial ~~disclosures~~and ~~required~~administrative ~~were originally addressed in our financial statements~~staff. Please refer to our Annual Report on Form 10-K as filed with the SEC on ~~June~~December 2820, 2011, for a complete discussion relating to the foregoing evaluation of Disclosures and Procedures.

1516

Changes in Internal Control over Financial Reporting

Our management has also evaluated our internal control over financial reporting, and there have been no significant changes in our internal controls or in other factors that could significantly affect those controls subsequent to the date of our last evaluation.

PART II - OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS.

From time to time, we are involved in routine legal matters incidental to our business. In the opinion of management, the ultimate resolution of such matters will not have a material adverse effect on our financial position, results of operations or liquidity.

Consistent with Item 103 of Regulation S-K, we are presently involved in the following material pending legal proceedings not incidental to the business of the Company:

OnIn March 2009, a lawsuit was filed in the United States District Court, District of Utah, Central Division, against Ethos Environmental, Inc. by Republic Bank. The lawsuit alleges that the Company breached the terms of a Lease Agreement involving Mazuma Capital Corp. and Ethos. Republic Bank is seeking monetary damages and return of certain equipment. On February 9, 2011, Summary Judgment was entered in favor of Republic Bank. The Company and Republic Bank finalized the terms of a settlement agreement during the 2nd quarter of 2011. The terms of the settlement are the forfeiture of the security deposit on the lease, the leased property, and payments totaling $200,000. The Company was indemnified by a group of shareholders against claims originating prior to the Merger, and as of ~~September~~December 120, 2011 such shareholders have paid approximately $~~117~~150,000 and are obligated to make monthly payments of $8~~.791~~,334 per month plus interest for through June 2012. If not paid by such shareholders, the Company would still be obligated to pay Republic Bank and then pursue its claim for indemnification against the shareholders.

In March 2011, a lawsuit was filed in the Superior Court of California, County of San Diego, South County Division against the Company by Frederick Chorney. The lawsuit alleges that the Company breached the terms of a consulting agreement between the Company and Mr. Chorney. Mr. Chorney is seeking monetary damages in the amount of $150,000. Mr. Chorney has requested a jury trial which is currently in the discovery stage. The Company, based on advice from council, cannot provide assurances as to the outcome of this matter at this time.

ITEM 1A.

RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Quarterly Issuances:

~~During~~In August 2011, the ~~quarter~~Company issued 30,000,000 wecommon ~~did~~shares ~~not~~with ~~issue~~a ~~any~~fair ~~unregistered~~value ~~securities~~of ~~other~~$600,000 ~~than~~pursuant asto ~~previously~~a ~~disclosed~~license agreement.

In August 2011, the Company issued 5,000,000 common shares with a fair value of $100,000 for services rendered.

In August 2011, the Company issued 26,842,727 common shares in connection with the conversion of convertible notes payable with a face amount of $475,000 and accrued interest of $30,878.

In September 2011, the Company issued 18,888,890 common shares in connection with the conversion of convertible notes payable with a face amount of $340,000.

Subsequent Issuances:

~~Subsequent~~In toOctober 2011, the ~~quarter~~Company issued 2,800,000 wecommon ~~did~~shares ~~not~~with ~~issue~~a ~~any~~fair ~~unregistered~~value ~~securities~~of ~~other~~$42,000 ~~than~~in asconnection ~~previously~~with ~~disclosed~~convertible notes payable issued in October 2011, in accordance with the terms of conversion in the notes.

In October 2011, the Company issued 500,000 common shares with a fair value of $7,500 for services rendered, valued at $.015 per share based on the Company’s common stock trading price at the time of issuance.

In November 2011, the Company issued 3,267,974 common shares for cash proceeds of $50,000, at $.015 per share.

In December 2011, Dr. Shirish Phulgaonkar resigned from his position as Chief Scientific Officer of the Company citing personal and health reasons.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.

[REMOVED AND RESERVED]

ITEM 5.

OTHER INFORMATION.

None.

ITEM 6.

EXHIBITS

The following exhibits are filed with this Quarterly Report on Form 10-Q:

Exhibit
Number	Description of Exhibit	Filing
3.01	Articles of Incorporation and Amendments	Filed with the SEC on April 6, 2000 as part of our Registration Statement on Form 10SB12G.
3.01(a)	Articles of Amendment to Articles of Incorporation	Filed with the SEC on April 25, 2006 as part of our Preliminary Information Statement on Form 14-C.
3.02	Bylaws	Filed with the SEC on April 6, 2000 as part of our Registration Statement on Form 10SB12G.
10.1	Stock Purchase Agreement between ETEV and MKM Opportunity Master Fund, Limited dated August 1, 2008.	Filed with the SEC on August 14, 2008 as part of our Quarterly Report on Form 10-Q.
10.2	Stock Purchase Warrant issued to MKM Opportunity Master Fund, Limited dated August 1, 2008.	Filed with the SEC on August 14, 2008 as part of our Quarterly Report on Form 10-Q.
10.3	Stock Purchase Warrant issued to MKM Opportunity Master Fund, Limited dated October 1, 2008.	Filed with the SEC on November 19, 2008 as part of our Quarterly Report on Form 10-Q.
10.4	Stock Purchase Warrant issued to MKM Opportunity Master Fund, Limited dated December 1, 2008.	Filed with the SEC on January 14, 2009 as part of our Current Report on Form 8-K.
10.5	Operating Agreement between ETEV and ecoMates, LLC dated March, 2009.	Filed with the SEC on April 15, 2009 as part of our Year End Report on Form 10-K.
10.6	Operating Agreement between ETEV and Ethos Scientific, LLC dated March, 2009.	Filed with the SEC on April 15, 2009 as part of our Year End Report on Form 10-K.
10.7	Common Stock Purchase Warrant issued May 8, 2009 to MKM Opportunity Master Fund.	Filed with the SEC on May 13, 2009 as part of our Current Report on Form 8-K.
10.8	Form of Stock Purchase Warrant dated August 5, 2009.	Filed with the SEC on August 11, 2009 as part of our Current Report on Form 8-K.
10.9	Form of Securities Purchase Agreement dated August 5, 2009	Filed with the SEC on August 11, 2009 as part of our Current Report on Form 8-K.
10.10	Stock Purchase Warrant issued to Carrillo Huettel, LLP dated April 28, 2009.	Filed with the SEC on August 14, 2009 as part of our Quarterly Report on Form 10-Q.
10.11	Assignment Agreement between Thrive Worldwide, LLC and MKM Opportunity Master Fund, Limited dated October 7, 2009.	Filed with the SEC on October 14, 2009 as part of our Current Report on Form 8-K.
10.12	Securities Purchase Agreement and Promissory Note issued to MKM Opportunity Master Fund, Limited dated November 2, 2009.	Filed with the SEC on November 9, 2009 as part of our Current Report on Form 8-K.
10.13	Agreement and Plan of Merger between ETEV and Youngevity dated November 21, 2009	Filed with the SEC on November 25, 2009 as part of our Current Report on Form 8-K.
14.1	Code of Ethics	Filed with the SEC on April 15, 2009 as part of our Annual Report on Form 10-K.
21.1	List of Subsidiaries	Filed with the SEC on June 28, 2011 as part of our Annual Report on Form 10-K.
31.01	Certification of Principal Executive Officer Pursuant to Rule 13a-14	Filed herewith.
31.02	Certification of Principal Financial Officer Pursuant to Rule 13a-14	Filed herewith.
32.01	Chief Executive Officer and Chief Financial Officer Certification Pursuant to Section 906 of the Sarbanes-Oxley Act	Filed herewith.

Index to Exhibits


Exhibit
Number	Description of Exhibit	Filing
3.01	Amended and Restated Articles of Incorporation	Filed with the SEC on May 24, 2011 as part of our Definitive Information Statement on Schedule 14C.
3.02	Amended and Restated Bylaws effective as of January 20, 2011	Filed with the SEC on December 20, 2011 as part of our Annual Report on Form 10-K.
10.1	Agreement and Plan of Merger by and among Ethos Environmental, Inc., EEI Acquisition Corporation and Regeneca International, Inc. dated December 14, 2010	Filed with the SEC on January 4, 2011 as part of our Current Report on Form 8-K.
14.1	Code of Ethics	Filed with the SEC on April 15, 2009 as part of our Annual Report on Form 10-K.
16.1	Letter from former independent public accountant for the registrant, M&K CPAS, PLLC, dated September 16, 2011	Filed with the SEC on September 20, 2011 as part of our Current Report on Form 8-K.
21.1	List of Subsidiaries	Filed with the SEC on December 20, 2011 as part of our Annual Report on Form 10-K.
31.01	Certification of Principal Executive Officer Pursuant to Rule 13a-14	Filed herewith.
31.02	Certification of Principal Financial Officer Pursuant to Rule 13a-14	Filed herewith.
32.01	Chief Executive Officer and Chief Financial Officer Certification Pursuant to Section 906 of the Sarbanes-Oxley Act	Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

REGENECA, INC.

Dated: ~~September~~December 1320, 2011

By:

/s/ Matthew Nicosia

MATTHEW NICOSIA

Chief Executive Officer ~~(Principal Executive Officer), President and Director~~

(Principal Executive Officer),

President and Director

/s/ Daniel Kerker

DANIEL KERKER

Chief Financial Officer ~~(Principal Financial Officer~~

~~and~~ (Principal ~~Accounting~~Financial Officer) ~~and Treasurer~~

18and Principal Accounting

Officer) and Treasurer

Filing Compare · Regeneca, Inc.